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Placental tissue is a source of receptors for some 
yolypeptidic 19orn9ones including insulin [B ] an9d 
somatomedin [CT]_ Hn addition it produces some 
chorionic, pituitary-like hormones, such as 
gonadotroph9 [3], somatomammo?ropin 141 , cortico- 
tropin ES]_ A recent report [6] indicates that human 
full term placenta rontzins 61-lipotropin and 
f&endorplnin. j3-Endorpbin is a polypeptide with 
morphine-like properties that exhibits a high affinity 
for opiate receptors in brain and peripheral tissues 
JT-(PI. Evidence will be presented here Pbat hw9an 
placenta contains substantial amo9mts of stereo- 
specific binding sites for [%]etorphine, a potent 
opiate agonist. 
2.1. Bmpm-&ion of hvcvvvava pimental vvzevvvbravves 
Placentae were collected on ice immediately after 
caesarian sectiol9, minced with scissors and washed 
several til99es with cold physiologica seru199. AlI 
~urt~ier operations were carried auf at 4°C. The tissue 
was freed from blood vessels and connective tissue, 
and homogenized in 5 vol..Tris--MC1 buffer 0.05 M 
at pH 7.4 in a Potter Elvehjem (5 strokes). The 
homogenate was centrifuged (1000 X g for 10 min] 
and the sulpernatant fluid was spun at P 00 000 X g 
for 30 min; the resulting pellet was washed once and 
spun again for an additional 30 min & IO0 ~CDO X g. 
The final pellet was homogenszed, the99 diluted with 
buffer to give - 1 rng protein/ml final coI9c. _. 
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2.2. Bivxfivvg assay 
The reaction mixtures (1 ml) contained 0.8 mg 
protein, P pm01 [3M]etorphine with. or without 
1 nrnol unlabelled etorphine. They were incubated, 
always in quadruplicate, at 37=C for 30 min. Imme- 
diately after incubation, they we?:: filtered under 
reduced pressure through Whatman glass fibre disks 
(GFB) and washed with 10 ml of ice-cold Tris buffer. 
The filters were dried and counted in 10 ml toluene 
scintillation cocktail. Protein concentrations were 
estimated by the method in [I Qj_ Specific [‘HJetor- 
pP9ine binding was defined as the difference between 
Ihe.radioactivity bound to membranes in the absence 
and in the presence of 1 ~_IM of non-radioactive 
etorphine. 
[ 15,3 6($-3H]etorp?hine, 35.4 Ci/mmol, the Radio- 
chemica! @enter, Amersham; Dextrorphan and Lever- 
phanol. Hoffman-La Troche, Basel; Naioxone, Endo, 
Brussels; MorphiPae, Francopia, Paris; D-Ala-Leu- 
enkephlinamide, Dr MazargMl, Toulowe. 
3. Wesnlts 
The time course of f3H]etorphine binding PO 
placental membranes is hown ipn fig.1. At 37°C 
specific bin&ng of the tritiated l&and (I nMj reached 
eq99i8i’urium within - BO nrin and remained constanat 
at least up to 40 min. 
Reversibility of [3H]etorph&ne binding was 
demonstrated by the addition of 10-’ M wlabelled 
etorphine wbicb res&ed in a compkte dissociation 
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Fig.1. [%]Etorphine bindiilg tc human placental membranes 
a~ a function of time. [%]Etorphine (POV9 M) was incubated 
with placental membranes (1 mg protein/ml) for the indicated 
periods of time at 37°C with (a) or without u&belled 
etorphine 1W6 M; the specific 13H]etorphine binding (0) 
was determined as in ::ection 2. 
of the specifically labelled complex within 10 min ilt 
37°C. Analysis of the kinetics studies represented in 
fig.2 indicated an association constant K1 df 
0.15 X 10’ M-’ .min-” and a dissociation rate 
constant K_, of G-G75 min-’ _ 
Specific binding of E3H]etorphine (in the range 
Cl.1 25-4 X 1 O-’ M) to the placental membrane 
fragments was satnrable. A Scatchard analysis 
indictited a single class of non-interacting binding si-!es 
with amU, of0.59 IL 0.13 lo-’ M (mean k SEM, ?I = 5) 
and a binding capacity of - 70 fmoljn?g protein. Gne 
experiment is shown in fig.3. The Kd value, derived 
from the Scatchard plot (0.59 X i Oe9 RI) agreed very 
well with the Kd value of 0.35 X 1 0W9 M calcul:&ed 
from the ratio K_,, ,K, . _ 
We have measured the Kd and the capacity of 
[3N]etorphine binding site on the membranes of TWO 
placentae obtained from early pregnancies. The values 
obtained were Kd 0.45 n&I, capacity 44 fmoljmg 
Fig.2.Determinatio~ ofrate constants. Analysisofassociation (left panel): [RHeq], concentration of the complelt [“Hletorphine-- 
membrane at equilibrium; [RH 1, concentration of Phe complex [%]etorphine--membrane at a given time. The line determined by 
linear regression analysis (r = 0.98) has a slope of K ob., K, is calculated from K, = K ob. -K_, /fetorphine] where K_, is the 
first order rate constant for disociafion and [etowhine] the concentration of [‘]etorphIrre io ths aszy (1.25 nM1. Xeversiiility 
of [3H~etorphine bkding to ~Cacer&al membranes (right panel). Membranes were incabated with [“H]etorphine at 37°C for 
20 r&n after which a ilarge excess of etorphine (IO-’ M) waz adtied. [RH], concentration of the complex [W]etorphine-mem- 
brane at a given time; [RA]o, concentration of the complex at 0 time of the dissociation studies. The line determined by linear 
regression analysis (r = 0.99) has a slope (K_I ) of 0.075 min:’ . 
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phine to placental membranes in the presence and ~~~~~w~~ge~e~t~ 
in the absence of lciQ mM N&l. The stereospecific 
binding of [3H]etorphine was reduced by 75 1 5% This work was supported by Action Th&natique 
(rnean I SEM, Pl= 3). ProgrammCe Pharmacollogie Bkinatde no. 337665 
from the Institut National de Is Sante et de la 
4.llxScw~!iOp1 
Thk study has shown that [3W]etorphine binds 
reversibly and with a hi& affinity & 0.6 nM) to 
saturable sites in a membraane fraction of human 
placenta, This binding is stereospecific because it is 
not inhibited by dextrorphan [at 3 1 O-’ Ml but is 
maximally inhibited by 110e6 M Bevorphanol. 
Morphine, naloxone and D-~~a-~u-eplke~~alinamide 
are able to compete with [3H$torphine for binding 
to p]acental membranes: the pi values for naloxone 
and levorphanol are similar to those measured for 
these compounds in brain [I 21. The very !ow affinity 
ofrnorphine for [‘Hjjetorphine binding sites might 
result from metabolic inactivation of the drug by the 
placenta1 microsomes present in our membrane 
fraction. Jn fact, the placenta of rnanj~ species, 
including man, is known to exhibit drug metabolizing 
activity [14j. Stereospecific binding.of [%]etorphine 
to placental membranes is reduced in the presence of 
NaCI. Thus [3M]etorphine binding to sites from 
placental membranes have several characteristics in 
cornrnon with opiate receptors from other tissues 
[l2,13j. 
It seems likely that the ability of human placenta 
to bind opiates stereospecifically exists early in 
pregnancy and presents properties analogous to those 
described in h&an full-term placenta. 
Placental tissue is devoid of innervation so that 
the biological significance of its opiate binding sites 
remains to be ekcidated. 
Recherche M65cZicle (INSERM). We are fqateful for 
the he]pM advice of Dr 9. CL Meuniea and 
Dr H. Grandjean (Toulouse) tbrougho~~t the prepzra; 
tion of the mamwript. 
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